66ac3b4c__Working_Group_Recommendations__Genetic_Test_Purpose
[Disease/Condition] Diabetes: [Test Use] Association of a genetic marker(s) with T2D risk profiling in general and high risk populations. [EGAPP Recommendation] *The EGAPP Working Group (EWG) found insufficient evidence to recommend testing for predictive variants in 28 variants (listed in Table 1) to assess risk for Type 2 Diabetes in the general population, based on studies in populations of northernEuropean descent. *The EGAPP Working Group (EWG) found insufficient evidence to recommend testing for the TCF7L2 gene to assess risk for Type 2 Diabetes in high-risk individuals. Read the EGAPP recommendation (March 2013) [Genetic Test/Purpose] 
Does genomic profiling to assess Type 2 Diabetes (T2D) risk improve health outcomes?
EGAPP|Working Group|Recommendations
Genetic Test/Purpose